Lexicon Pharmaceuticals LXRX Increase (Decrease) in Other Operating Assets
Increase (Decrease) in Other Operating Assets at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's increase (decrease) in other operating assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's increase (decrease) in other operating assets?
- Lexicon Pharmaceuticals (LXRX) reported increase (decrease) in other operating assets of -$195K in Q1 2026.
- How has Lexicon Pharmaceuticals's increase (decrease) in other operating assets changed year-over-year?
- Lexicon Pharmaceuticals's increase (decrease) in other operating assets decreased by 4.8% year-over-year, from -$186K to -$195K.
- What is the long-term trend for Lexicon Pharmaceuticals's increase (decrease) in other operating assets?
- Over 2 years (2021 to 2025), Lexicon Pharmaceuticals's increase (decrease) in other operating assets has grown at a 7.0% compound annual growth rate (CAGR), from -$661K to -$757K.
- What does increase (decrease) in other operating assets mean?
- This captures the net change in miscellaneous assets that are not classified as loans, securities, or property, plant, and equipment. It often includes items like accrued interest receivables, prepaid expenses, and other short-term operational assets.